Ashish Nimgaonkar
Company: Glyscend
Job title: Founder & Chief Executive Officer
Seminars:
Forging Success in Type 2 Diabetes: Treatment & Reversal of T2D & Interrogating Cross-Talk in Metabolic Syndrome 2:00 pm
Investigating cross talk in metabolic syndrome: from T2D to obesity to NASH Does T2D represent an attractive path to market? Understanding market access with opportunities and implications in NASH and obesity Pioneering a new generation of gut-targeted polymer therapies to achieve pharmacologic duodenal exclusion: targeting the root cause of metabolic syndrome, improving blood glucose, and…Read more
day: Day 2 Stream 1 PM